Search

Search Constraints

You searched for: Author/Creator Mahlangu, Johnny N.

Search Results

1. A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH. (29th July 2021)

2. A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia. (23rd August 2022)

5. Development and testing of the Satisfaction Questionnaire with Intravenous or Subcutaneous Hemophilia Injection and results from the Phase 3 HAVEN 3 study of emicizumab prophylaxis in persons with haemophilia A without FVIII inhibitors. Issue 2 (28th January 2021)

6. Establishment of a framework for assessing mortality in persons with congenital hemophilia A and its application to an adverse event reporting database. (16th December 2020)

7. Health‐related quality of life and health status in adolescent and adult people with haemophilia A without factor VIII inhibitors—A non‐interventional study. Issue 3 (12th February 2021)

8. Long‐acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B‐LONG study. (11th September 2014)